Litalsa, Erle Robotics and Histocell: Basque companies that have received rounds in the Basque Country

Integral service around a transaction
BY : Diego GutiérrezJuly Fri, 2015
In May, several Basque companies from different sectors received funding. Erle Robotics, a drone company, received €200,000 from 6 business angels. Histocell, located in Zamudio, has received €2.5 M to launch its new product and Realza has bought Litalsa, a leading independent supplier in the packaging lithography market.

Basque Country


Erle Robotics raises 200,000 euros in its funding round

The Alavesa drone company Erle Robotics, which stands out for its devices, developed with free software and hardware, has received a €200,000 funding round in which 6 business angels have participated, two Basque and four British.

 The company will use the funds to position its technology as a global pioneer and project its business internationally as it has just opened an office in Germany to strengthen its close relationship with the multinational. Bosch. Thanks to this foray into Germany, Erle Robotics has been selected by the German startup accelerator TechFounders to boost your business and develop new software for your device Erle Brain with new capabilities and sensors to enable new uses and applications.

"In addition, Elre Robotics intends to close another, larger round of financing in the second half of the year. Growth in this sector is essential to be able to compete. In Spain alone, the number of drone companies registered with AENA (Spanish airports and air navigation) has grown by 70 % so far in 2015. In addition, numerous internal companies have received million-dollar rounds in 2015, such as RD Robotics, which closed a $14M round in April" says Diego Gutierrez from Abra-Invest.

 Biopharmaceutical company Histocell receives round of funding

Biopharmaceuticals Histocell, located in the technology park of Zamudio, has closed a round 2.5m to bring its Reoxcare healing product to market, which is expected to be launched by the end of 2015. 

For the time being, the company has already reached agreements for the marketing of Reoxcare in different European and Asian markets, such as the one signed with the company Luqa Pharma for China, Hong Kong and Macao.

Histocell develops and commercialises medical devices and cell therapy medicines in the field of human health. In addition to the international launch of Reoxcare, the company plans to complete the development of three medical devices and to finalise the clinical phases I/IIa of two cell-based medicines in the five-year period 2015-2020.

 Realza buys Litalsa

Enhance Capital has bought a majority stake in the Basque company LitalsaAC Development, a leading independent supplier of lithography for packaging and mechanical closures, was in the hands of AC Development.

"For AC Desarrollo, the sale of Realza represents the first divestment of its AC Capital Premier II fund," says Diego Gutiérrez of AC Capital Premier II. Abra-Invest.

The purchase has been financed not only with equity but also with bank debt provided by Caixabank, Bankinter and Mutua.

With this investment, Realza expects to consolidate Litalsa's leadership in Spain and foster its international growth, accompanying existing customers.


If you are looking for financing in Abra -invest we can help you. Get in touch with us on +34.946024142

Other posts that may interest you

 biotech grows and finds alternative forms of finance

New funds for ICTs, Bio and internalisation (May)

The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?